Table 45Risk of fracture for raloxifene, relative to estrogen, among postmenopausal women

Author, YearStudy DurationFracture TypeNumber of Fractures, RaloxifeneNumber of Fractures, EstrogenOdds Ratio (95% CI)
Vertebral Fractures
Original 2007 Report
Reid, 200412236 monthsVertebral4/193*1/1021.9 (0.03, 12.22)
Update Report: No new studies
*

60 and 150 mg dose groups combined.

From: Results

Cover of Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report
Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report [Internet].
Comparative Effectiveness Reviews, No. 53.
Crandall CJ, Newberry SJ, Diamant A, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.